Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan)
Condition(s):Staphylococcal InfectionsLast Updated:July 2, 2012Completed
Hide Studies Not Open or Pending
Condition(s):Staphylococcal InfectionsLast Updated:July 2, 2012Completed
Condition(s):Renal Failure; Impaired Renal FunctionLast Updated:March 14, 2014Completed
Condition(s):Pulmonary Tuberculosis; Multidrug Resistant Tuberculosis; Extensively Drug Resistant TuberculosisLast Updated:March 14, 2016Completed
Condition(s):Gram Positive InfectionLast Updated:April 30, 2012Completed
Condition(s):Ventilator Acquired PneumoniaLast Updated:March 2, 2012Withdrawn
Condition(s):Multi-drug Resistant Tuberculosis; Extensively Drug Resistant TuberculosisLast Updated:October 2, 2012Completed
Condition(s):Tuberculosis; Multidrug Resistant TuberculosisLast Updated:October 6, 2023Recruiting
Condition(s):SepsisLast Updated:November 24, 2011Completed
Condition(s):Skin and Subcutaneous Tissue Bacterial InfectionsLast Updated:August 29, 2018Completed
Condition(s):Skin Infections, BacterialLast Updated:March 27, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.